iCellate (private company)
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechHealth servicesPharma
Business model:B2B
iCellate is a Swedish company founded in 2011 developing products in the field of cancer research and detection, more specifically circulating tumor cells (CTC).
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 13.59M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to iCellate
Name | Criteria | |
---|---|---|
![]() |
Cinclus Pharma
70%
|
|
![]() |
Causaly
70%
|
|
![]() |
Kither Biotech
70%
|
|
![]() |
Relation Therapeutics
70%
|
|
![]() |
SolasCure
70%
|
|
![]() |
ITBMed
65%
|
|
![]() |
Pila Pharma
65%
|
|
![]() |
PEP-Therapy
65%
|
|
![]() |
Atley Solutions
65%
|
|
![]() |
Vaxxel
65%
|
|